Open AccessIntersection of minority health, health disparities, and social determinants of health with psychopharmacology and substance use.
Author(s) -
Hector I. Lopez-Vergara,
Tamika C. B. Zapolski,
Adam M. Leventhal
Publication year - 2021
Publication title -
experimental and clinical psychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.066
H-Index - 92
eISSN - 1936-2293
pISSN - 1064-1297
DOI - 10.1037/pha0000522
Subject(s) - psycinfo , psychological intervention , context (archaeology) , psychology , mental health , psychological resilience , addiction , public health , psychopharmacology , medline , psychiatry , medicine , psychotherapist , political science , paleontology , nursing , law , biology
These articles provide a window into the breadth of issues at the intersection of MHDS with psychopharmacology and substance use. Integrating the fields of psychopharmacology and basic behavioral addictions science with research on MHDS is not only of public health importance, but can help further elucidate our understanding of human behavior in all of its complexity. As demonstrated here, a better understanding of the synergy between societal context(s) and individual-level processes can lead to interventions tailored to specific risk and resilience factors; interventions that are personalized and contextualized have the potential to improve the health of our society. We are very grateful to the authors for their contributions to this special issue. We hope that professionals from various disciplines who read this special issue become inspired to bridge psychopharmacological and social determinants perspectives in their own work, and, in turn, accelerate scientific progress within each field. (PsycInfo Database Record (c) 2021 APA, all rights reserved).